Clinical Trial Update: Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the tolerability and pharmacokinetics of a capecitabine regimen given 5 days out of 7 in patients with breast cancer under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | Conditions: Breast Neoplasms, Chemotherapy | Phase 1, Phase 2 | Status: UNKNOWN